ReviewInternational journal of general medicine2026
Advances in the Application of Musculoskeletal Ultrasound in the Diagnosis of Rheumatoid Arthritis: A Review.
Review in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily targets the joints, causing persistent inflammation, progressive joint destruction, and functional disability. Early and accurate diagnosis is essential for initiating timely treatment and improving patient outcomes. Musculoskeletal ultrasound (MSUS), a non-invasive and real-time imaging technique, has attracted considerable interest for its high-resolution visualization and ability to assess joints dynamically. This narrative review synthesizes current literature on the role of MSUS in the diagnosis of RA, with particular emphasis on its unique value in the early detection of subclinical synovitis and in supporting the diagnosis of seronegative RA, where conventional serological markers are absent. MSUS enables sensitive detection of synovial hypertrophy, tenosynovitis, joint effusion, increased vascularity on power Doppler imaging, and early bone erosions, facilitating timely recognition of inflammatory activity and structural damage. Despite these advantages, limitations such as operator dependence and variability in standardization remain. Recent advances-including consensus-based EULAR-OMERACT definitions and scoring systems, standardised scanning protocols, and emerging artificial intelligence applications-have broadened the clinical value of MSUS, indicating promising opportunities for its incorporation into routine RA management. This article aims to synthesize existing evidence, address ongoing challenges, and explore future directions to further enhance the diagnostic and monitoring capabilities of MSUS in patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.